BioStem Technologies (BSEM) to Release Earnings on Monday

BioStem Technologies (OTCMKTS:BSEM) is expected to be issuing its quarterly earnings data after the market closes on Monday, April 7th. Analysts expect the company to announce earnings of $0.37 per share and revenue of $86.69 million for the quarter.

BioStem Technologies Trading Up 0.3 %

Shares of BSEM opened at $9.13 on Monday. The firm has a market cap of $152.51 million, a PE ratio of 13.43 and a beta of -0.39. BioStem Technologies has a 12 month low of $6.77 and a 12 month high of $28.26. The stock has a fifty day moving average price of $13.38 and a 200-day moving average price of $13.87.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.